Quick Answer
INTENSITY THERAPEUTICS, INC. reported Diluted EPS of $8.56 per share (loss) for fiscal year 2025.
INTENSITY THERAPEUTICS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$8.56 | +70.7% |
| 2024 | -$29.24 | -2018.8% |
| 2023 | -$1.38 | +37.8% |
| 2022 | -$2.22 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.06 | +76.0% | +53.8% |
| June 30, 2025 | -$0.13 | +63.9% | +40.9% |
| March 31, 2025 | -$0.22 | +35.3% | +12.0% |
| September 30, 2024 | -$0.25 | -47.1% | +30.6% |
| June 30, 2024 | -$0.36 | +74.8% | -5.9% |
| March 31, 2024 | -$0.34 | +12.8% | -100.0% |
| September 30, 2023 | -$0.17 | +67.3% | +88.1% |
| June 30, 2023 | -$1.43 | -150.9% | -266.7% |
- INTENSITY THERAPEUTICS, INC. showed an increase of +70.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, INTENSITY THERAPEUTICS, INC.’s diluted eps has declined by 285.6% (from $2.22 per share (loss) to $8.56 per share (loss)).
- The most recent figure is from INTENSITY THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: